These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10166705)

  • 21. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carvedilol prospective randomized cumulative survival (COPERNICUS) trial: carvedilol as the sun and center of the beta-blocker world?
    Wollert KC; Drexler H
    Circulation; 2002 Oct; 106(17):2164-6. PubMed ID: 12390940
    [No Abstract]   [Full Text] [Related]  

  • 23. Carvedilol for heart failure.
    Med Lett Drugs Ther; 1997 Sep; 39(1010):89-91. PubMed ID: 9323960
    [No Abstract]   [Full Text] [Related]  

  • 24. [Patient with heart failure. Beta blockage becomes mandatory].
    Einecke D
    MMW Fortschr Med; 2000 Sep; 142(36):14-6. PubMed ID: 11021061
    [No Abstract]   [Full Text] [Related]  

  • 25. Slowing the progression of heart failure.
    Cohn JN
    Eur Heart J; 1996 Nov; 17(11):1609-11. PubMed ID: 8922902
    [No Abstract]   [Full Text] [Related]  

  • 26. [COMET: metoprolol].
    Handa S
    Nihon Rinsho; 2007 Apr; 65 Suppl 4():521-5. PubMed ID: 17511103
    [No Abstract]   [Full Text] [Related]  

  • 27. [Severe heart failure--effects of carvedilol therapy. The Copernicus Study].
    Kindermann M; Böhm M
    Internist (Berl); 2002 Feb; 43(2):284-6. PubMed ID: 11963765
    [No Abstract]   [Full Text] [Related]  

  • 28. Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?
    Fowler MB
    Eur Heart J; 1998 Dec; 19 Suppl P():P17-25. PubMed ID: 9886708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of carvedilol on survival in severe chronic heart failure. A trial of the beta-blocker bucindolol in patient with advanced heart failure].
    Bosimini E
    Ital Heart J Suppl; 2001 Aug; 2(8):919-21. PubMed ID: 11582729
    [No Abstract]   [Full Text] [Related]  

  • 30. Major beta blocker mortality trials in chronic heart failure: a critical review.
    McMurray JJ
    Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
    [No Abstract]   [Full Text] [Related]  

  • 31. [Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
    Sinagra G; Boccanelli A; Camerini F; Gavazzi A; Gronda E; Maggioni AP; Opasich C; Rapezzi C; Scherillo M; Tavazzi L
    G Ital Cardiol; 1998 Jan; 28(1):61-70. PubMed ID: 9493048
    [No Abstract]   [Full Text] [Related]  

  • 32. A comment on COMET: how to interpret a positive trial?
    Massie BM
    J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
    [No Abstract]   [Full Text] [Related]  

  • 33. Carvedilol [Coreg].
    Kukin M
    Compr Ther; 1997 Sep; 23(9):617-20. PubMed ID: 9285163
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of carvedilol on mortality and morbidity in patients with chronic heart failure.
    Circulation; 1996 Aug; 94(4):592. PubMed ID: 8772669
    [No Abstract]   [Full Text] [Related]  

  • 35. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.
    Shepherd AM
    J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784
    [No Abstract]   [Full Text] [Related]  

  • 36. Which beta-blocker for heart failure?
    Patel MR; Gattis W
    Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial].
    Costalunga A; Gavazzi A
    Ital Heart J Suppl; 2001 Nov; 2(11):1246-7. PubMed ID: 11775420
    [No Abstract]   [Full Text] [Related]  

  • 38. [A randomized comparison of carvedilol and metoprolol in patients with chronic heart failure. The Carvedilol Or Metoprolol European Trial (COMET) ].
    Torp-Pedersen CT;
    Ugeskr Laeger; 2004 Aug; 166(32):2671-4. PubMed ID: 15347171
    [No Abstract]   [Full Text] [Related]  

  • 39. Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial.
    Gattis WA; O'Connor CM; Gallup DS; Hasselblad V; Gheorghiade M;
    J Am Coll Cardiol; 2004 May; 43(9):1534-41. PubMed ID: 15120808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Drug therapy of chronic heart failure: when are beta receptor blockers indicated?].
    vom Dahl J; Schotten U; Sasse A
    Dtsch Med Wochenschr; 1999 Sep; 124 Suppl 2():S48-53. PubMed ID: 10535047
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.